| Name | Title | Contact Details |
|---|
Cellanyx has developed proprietary live tumor cell phenotypic biomarker tests to improve cancer risk-stratification and allow informed clinical decision making. The Companys unique approach provides quantitative and actionable information based on analysis of thousands of live tumor cells. The Companys tests employ a microfluidic platform combined with machine vision and machine learning approaches to analyze phenotypic morphological, biochemical and biophysical markers. Cellanyx has demonstrated initial clinical proof-of-concept with its lead phenotypic test in prostate cancer. The initial clinical proof-of-concept study was conducted to demonstrate improved risk stratification in men with low and intermediate Gleason grade (6 and 7) disease and reduce the number of repeat biopsies. Furthermore, analysis of field samples (away from the suspicious core) demonstrated the potential value of Cellanyx phenotypic test as it was able to analyze the tumor microenvironment conditions and predict expected adverse pathology from samples that were not taken from the suspicious core. These new findings from the Cellanyx prostate test are transformative as it will reduce the errors in diagnosing cancers early due to sampling heterogeneity of prostate biopsies.
Dinatec is a Gainesville, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Community Hospital Corporation owns, manages and consults with hospitals through three distinct organizations — CHC Hospitals, CHC Consulting and CHC ContinueCARE, which share a common purpose to guide, support and enhance the mission of community hospitals and healthcare providers.
DermOne is a leading dermatology practice management support organization providing unparalleled business and administrative support services to dermatologists across the United States. At DermOne, we are focused on affiliating with exceptional dermatologists who are committed to delivering innovative solutions and unsurpassed care to keep patients’ skin healthy and beautiful. DermOne’s proven practice support model allows dermatologists to focus on what they enjoy most – taking great care of patients - while benefitting from DermOne’s business expertise, state of the art systems, and shared best practices. Our philosophy is simple – if we take great care of physicians, they in turn can take great care of patients. DermOne is expanding its team of affiliated physicians, a group with diverse experience and expertise who is committed to providing the very highest standard of care for all skin, hair and nail conditions. Supported by DermOne’s Chief Medical Officer and a nationally recognized Clinical Advisory Board, DermOne affiliated physicians are part of a professional, evidence-based community with access to the latest tools, advanced treatment protocols and technologies. DermOne fosters true teamwork and collaboration, while ensuring physicians maintain autonomy in all clinical decision making. Each of DermOne’s affiliated physicians provide comprehensive, compassionate care – delivered expertly and professionally. This commitment is honored in all of the clinical services provided, including: complex medical and surgical dermatology, pediatric and adolescent dermatology, cosmetic dermatology, Mohs micrographic skin cancer surgery, facial plastic and reconstructive surgery, and vein care. Schedule an appointment at any of DermOne’s affiliated practice locations. One of our affiliated physicians looks forward to caring for you.
Hospice of Central Michigan, Inc. is a Mount Pleasant, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.